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sensing and effector pathways, lipoproteins, and extracel-
lular enzymes ( 1–5 ). Loss of cellular or plasma lipid con-
trol, generally referred to as dyslipidemia, can be caused 
by dysfunction in one or more of the multiple pathways 
responsible for lipid synthesis ( 6, 7 ), dietary fat utiliza-
tion ( 8 ), lipid catabolism ( 9 ), fat mobilization ( 10–12 ), lipid 
storage ( 11, 13 ), lipoprotein transport ( 14–16 ), and cellular 
energetics ( 17–19 ). Hypercholesterolemia and hypertrig-
lyceridemia are etiopathological causes of atherosclerosis, 
pancreatitis, fatty liver disease, and cancer ( 2, 5, 17, 20–22 ). 
Collectively, these diseases represent signifi cant public 
health and fi nancial burdens on all societies. Mainly due 
to societal changes in diet and lifestyle, as well as other 
recent environmental infl uences, dyslipidemia and related 
metabolic syndromes are currently rampant. 
 The liver is the epicenter of lipid and lipoprotein syn-
thesis and metabolism ( 23, 24 ). Proper control and main-
tenance of cellular and plasma lipid content require 
precise hepatic gene regulation at transcriptional, posttran-
scriptional, and posttranslational levels. Multiple hepatic 
transcription factors (TF), including peroxisome prolifera-
tor activated receptors (PPAR family) ( 25, 26 ), liver X re-
ceptors (LXR family) ( 27 ), hepatocyte nuclear factors (HNF 
family) ( 1, 28, 29 ), cAMP response element binding pro-
tein (CREBP) ( 30 ), CCAAT enhancer binding proteins 
(C/EBP family) ( 31, 32 ), forkhead box transcription factors 
(FOX family) ( 33–35 ), and sterol-response element bind-
ing proteins 1 and 2 (SREBF1 and SREBF2) ( 36–39 ), have all 
been found to control gene networks that govern lipid syn-
thesis, catabolism, storage, and secretion. Recent studies sug-
gest that posttranscriptional microRNA (miRNA)-mediated 
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independently along multiple lineages. A recent large-scale 
meta-analysis of hundreds of smRNA data sets has system-
atically identifi ed   240 human miRtrons, many of them 
evolutionarily recent ( 76 ). Finally, one highly conserved 
pre-miRNA (pre-miR-451) has been demonstrated to by-
pass DICER processing altogether and is instead cleaved 
directly by Argonaute 2 (Ago2) within the RISC ( 79–81 ). 
 MIRNAS CONTROL HEPATIC LIPID METABOLISM 
 miRNAs bind to target RNAs through complementary 
base pairing, most critically in the seed region of the 
miRNA (nucleotides 2 through 7 at the 5 ′ -end). One of 
the fi rst miRNAs shown to have a role in lipid biology is 
miR-33, which is cotranscribed with the SREBF family of 
genes and is a critical regulator of lipoprotein metabolism 
and fatty acid oxidation ( 44, 46, 49, 82 ). The functional 
relevance of miR-33 to lipid homeostasis has been estab-
lished in both mice and in nonhuman primates with 
systemic administration of chemically modifi ed locked 
nucleic acid (LNA), which mediates safe and potent inhi-
bition of endogenous miRNAs in vivo ( 46, 55, 83 ). Most 
recently, miR-33 has also been suggested as a key link 
between lipid metabolism and hepatocyte cell prolifera-
tion, particularly in the context of response to liver injury 
( 47, 84 ). 
 Using in silico strategies for miRNA target prediction 
and enrichment analysis, we recently identifi ed several 
miRNAs, including miR-27, miR-223, and miR-125, as can-
didate regulatory hubs in the pathways that govern lipid 
homeostasis ( 85 ). We demonstrated in vitro in human 
hepatocytes that miR-27b represses the expression of 
glycerol-3-phosphate acyltransferase 1 (GPAM), angiopoi-
etin-like 3 (ANGPTL3), peroxisome proliferator-activated 
receptor   (PPAR  ), and heparan sulfate N-deacetylase/
N-sulfotransferase 1 (NDST1) ( 15, 85–91 ). Inhibition of 
miR-27b in hepatocytes resulted in a signifi cant increase in 
GPAM mRNA and protein levels. GPAM-mediated acyl es-
terifi cation of glycerol-3-phosphate (sn-1 position) is the 
fi rst committed (enzymatic) step in triglyceride (TG) bio-
synthesis, and thus, miR-27b upregulation in a short-term 
high-fat diet is likely an adaptive response to mitigate TG 
production and attenuate hyperlipidemia and hepatoste-
atosis. Likewise, elevated hepatic miR-27b also represses 
 ANGPTL3 , which is produced and secreted from the liver 
to inhibit plasma TG lipolysis ( 92, 93 ). Heparin sulfate 
proteoglycans on hepatocyte membranes contribute to 
the cellular uptake of TG-rich lipoproteins, and loss of 
NDST1, the heparin sulfate biosynthetic enzyme, results in 
decreased TG-rich and cholesterol-rich lipoproteins in the 
liver ( 88 ). Although diet-induced dyslipidemia results in 
elevated plasma cholesterol and TG, miR-27b upregula-
tion in the liver likely protects the liver from extensive 
lipid accumulation by repressing NDST1 activity and 
heparin sulfate biosynthesis and, thus, reducing TG-rich 
lipoprotein uptake in the liver. Subsequent in vivo experi-
mentation in  Apoe   /   mice showed that in response to a 
high-fat/high-cholesterol diet, miR-27b is also signifi cantly 
gene regulation may also be highly relevant to the control 
of hepatic lipid metabolism ( 40–50 ). miRNAs have emerged 
not only as stable plasma biomarkers of metabolic states 
but also as attractive therapeutic targets for various cardio-
metabolic disorders ( 46, 51–55 ). Recent advances in small 
RNA (smRNA) high-throughput sequencing have unveiled 
the enormous complexity of the repertoire of functional 
smRNAs. Here, we review the current state of knowledge 
regarding the diversity of smRNAs, including miRNA 
isomiRs, and their control of lipid metabolism. 
 SMALL RNA DIVERSITY 
 Small noncoding RNAs can be stratifi ed into one of 
several categories based on their biogenesis mechanism, 
parent RNA type, and length: miRNAs (  22 nt in length) 
( 56, 57 ), Piwi-interacting RNAs (piRNA,   26–31 nt) 
( 58–60 ), small nucleolar RNAs (snoRNAs, 70–120 nt) 
( 60 ), small RNAs derived from snoRNA (sdRNA,   17–19 
nt) ( 61–63 ), endogenous small interfering RNAs (endo-
siRNA,   21 nt) ( 59, 64 ), small RNAs derived from vault 
RNA (svRNA,   17–19 nt) ( 65, 66 ), small RNAs derived 
from tiny RNA (tiRNA,   17–19 nt) ( 67, 68 ), and tRNA-
derived RNA fragments (tRFs,   17–19 nt) ( 61, 69 ). Although 
each of these classes of smRNA is thought to regulate gene 
expression through diverse mechanisms, miRNAs are cur-
rently the most widely studied and are known to be in-
volved in posttranscriptional control of lipid homeostasis 
( 56, 57, 70 ). 
 The human genome encodes for over 1,000 miRNAs, 
either within host protein-coding genes or as independent 
transcription units ( 56, 71 ). Canonical biogenesis of a 
miRNA commences with RNA Polymerase II-mediated tran-
scription, yielding a primary miRNA transcript (pri-miRNA) 
of variable length depending on the locus ( 56, 59, 72 ). 
The pri-miRNA is cleaved by a nuclear RNase complex 
DROSHA/DGCR8, generating a precursor miRNA (pre-
miRNA) that has a hairpin-like secondary structure. The 
pre-miRNA is then exported via the exportin 5-dependent 
pathway to the cytoplasm, where it is subject to further en-
zymatic processing by DICER and its cofactors, produc-
ing a short dsRNA duplex (  22 bp) ( 56, 57, 59, 72 ). One 
strand of the duplex (mature miRNA) is loaded onto the 
RNA-induced silencing complex (RISC), which it guides 
and tethers to target mRNAs in order to regulate their sta-
bility and/or translational effi cacy ( 57, 73 ). 
 Some miRNAs are generated by alternative mechanisms, 
but they may still play a signifi cant role in lipid homeo-
stasis. For example, certain miRNA clusters that are in-
terspersed among Alu repeats in the genome have been 
shown to be transcribed by RNA Polymerase III ( 74 ). Also, 
short-length introns can form hairpin-like structures upon 
nascent transcription and be processed by RNA splicing 
machinery, rather than by DROSHA, and cleaved into 
pre-miRNA products. This class of miRNAs is referred to 
as miRtrons, due to their unique biogenesis from intron-
exon junctions ( 75–78 ). Although very few miRtrons 
are extensively conserved, they are present in both inverte-
brates and mammals, suggesting that they may have evolved 
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that isomiRs are loaded onto the RISC and recognize target 
mRNAs for gene repression ( 61, 113, 114 ). Some isomiRs 
actually match the genomic template, but differ in their 
5 ′ -start and/or 3 ′ -end positions ( Fig. 1 ). This is likely due 
to variable enzymatic processing during biogenesis and/
or exonuclease-mediated nucleotide trimming. Changes 
to the 5 ′ -start position of a miRNA are expected to alter 
the canonical seed sequences, thereby reshuffl ing the pro-
fi le of target mRNAs ( Fig. 2 ).  Recent studies have used 
gene reporter (luciferase) assays to demonstrate that two 
seed-shifted isomiRs have different targeting effects rela-
tive to their canonical counterparts ( 115, 116 ). Some isomiR 
sequences may diverge from the genome due to posttran-
scriptional enzymatic editing and/or tailing of specifi c 
nucleotides ( Figs. 1, 2 ). The most dominant type of RNA 
editing is adenosine deamination, which is commonly re-
ferred to as adenosine-to-inosine (A-to-I) editing, and occurs 
with highest frequency in noncoding regions (e.g., regula-
tory RNAs such as pre-miRNAs, 3 ′ untranslated regions, 
etc.) ( 117, 118 ). RNA editing events in the 5 ′ -end region 
of miRNA have been shown to redirect miRNA targeting 
activity and function ( 119, 120 ). For example, A-to-I edit-
ing in the seed region of miR-376a results in a new pool of 
mRNA targets for miR-376a, which includes a new target 
(enzyme) in the uric acid metabolism pathway ( 121 ). 
 Posttranscriptional tailing, also referred to as nontem-
plated nucleotide addition (NTA), is carried out by a di-
verse set of nucleotidyl transferases ( Fig. 2 ). At least 7 out 
of the 12 known nucleotidyl transferases are thought to 
mediate 3 ′ NTA ( 19 ). For example, the PAP-associated do-
main family (PAPD4/GLD2, PAPD5) and the mitochon-
drial poly(A) polymerase (MTPAP) have been found to add 
adenines to the 3 ′ -end of miRNAs, including several that 
are highly relevant to hepatic function, such as miR-122 
upregulated, while its target genes (GPAM and ANGPTL3) 
are signifi cantly downregulated ( 85 ). miR-27b overexpres-
sion in hepatocytes resulted in the signifi cant downregula-
tion of 27 lipid-related genes ( 85 ). These fi ndings lead to 
the hypothesis that miR-27b plays an adaptive role in con-
trolling systemic lipid levels. 
 miRNAs can simultaneously repress hundreds of genes 
and directly infl uence the output of many interconnected 
biological networks. Furthermore, miRNAs can also indi-
rectly infl uence network output by targeting key network 
hubs, such as transcription factors ( 94 ). For example, criti-
cal lipid-sensitive transcription factors controlling hepatic 
metabolism, such as the LXR and PPAR families, have 
been shown to be functional targets of multiple miRNAs 
(LXR  : miR-613; PPAR  : miR-21, miR-10b, miR-141; PPAR  : 
miR-23a, miR-27b, miR-130) ( 85, 94–99 ). Moreover, complex 
feedback loops between transcription factors and miRNAs 
appear to control hepatocyte differentiation and possibly 
other aspects of liver biology ( 100–102 ). Several other ca-
nonical miRNAs have been shown to infl uence lipid meta-
bolic pathways, including miR-122, miR-370, miR-378, and 
miR-758, and they are comprehensively discussed in nu-
merous recent review articles ( 43–45, 94, 103 ). 
 Although the discovery of alternative modes of miRNA 
biogenesis is relatively recent, several noncanonical miRNAs 
have already been shown to be relevant to lipid metabo-
lism. For example, a human miRtron, miR-1224, was found 
to be induced by lipopolysaccahride (LPS) and to directly 
target and regulate Sp1 transcription factor activity, which 
controls the expression of many lipid-related genes ( 77, 
104 ) including the LDL receptor ( 105–107 ). Another re-
cent study found that miR-451, which bypasses DICER pro-
cessing, is signifi cantly reduced in the livers of rats on 
high-fat diets ( 108 ), supporting an earlier study that found 
hepatic miR-451 to be downregulated in humans with non-
alcoholic steatohepatitis (NASH) ( 109 ). The relevant targets 
of miR-451 remain unknown and merit further investiga-
tion. Also, two miRNAs generated from the human mito-
chondrial (mt) genome (miR-1974 and miR-1978), most 
likely smRNA fragments derived from mt tRNAs, were 
found to be signifi cantly upregulated in human coronary 
artery endothelial cells (HCAEC) treated with oxidized 
low-density lipoprotein (oxLDL) ( 110 ). Most interestingly, 
putative mRNA targets for these miRNA-like small RNAs are 
signifi cantly downregulated upon oxLDL treatment in 
HCAECs ( 110 ). 
 ISOMIRS OF CANONICAL MIRNAS 
 Irrespective of the biogenesis mechanism, a single ge-
nomic locus can give rise to multiple distinct isoforms 
(isomiR;  Fig. 1 ) ( 111–113 ).  Initially, isomiRs were either 
undetected by conventional profi ling methods, such as 
qPCR, or dismissed as experimental artifacts with limited 
biological relevance. Nevertheless, sophisticated new tech-
nologies and computational analyses of smRNA sequenc-
ing datasets have demonstrated that they are often present 
in far higher frequencies than previously appreciated. More-
over, subsequent biochemical experiments have revealed 
 Fig.  1. Sources of isomiR diversity. The top panel illustrates 
sources of isomiR diversity, which stratify into two classes: templated 
and nontemplated variations. As illustrated by the bottom panel, 
an isomiR may contain one or both types of variations, and both 
templated (e.g., 5 ′ -shifts) and nontemplated (e.g., RNA edits) vari-
ations can create an isomiR with an altered seed. The seed region 
of each isomiR is underlined in blue. 
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PCR and NanoString technology ( 125 ). This high-through-
put technique directly detects miRNA sequences, provides 
high precision, and allows for linear range of quantifi ca-
tion of a large number of samples ( 125 ). Another recent 
study has used mass spectrometry (MS) to observe and 
characterize miRNA isomiRs ( 122 ). 
 Several studies have reported that 3 ′ NTAs alter miRNA 
stability and activity ( 34–40 ). As such, NTAs represent a 
means by which miRNAs themselves are posttranscription-
ally regulated, which adds another layer of biological com-
plexity to miRNA-mediated gene regulation. The most 
prevalent 3 ′ NTAs are adenylation and uridylation, which 
appear to confer different functions for different miRNAs 
( 31 ). One seminal study reported that the same miRNA 
can have varying 3 ′ -NTA frequencies across different de-
velopmental stages, indicating for the fi rst time that isomiR 
production is biologically regulated. For a detailed discus-
sion of the biogenesis and functional signifi cance of isomiRs, 
we direct the reader to two comprehensive review articles 
(Refs.  112 and  126 ). 
 ISOMIRS IN LIPID METABOLISM 
 We recently performed smRNA sequencing to profi le 
hepatic miRNA changes in response to diet-induced dys-
lipidemia, and we identifi ed miR-27b as a candidate 
regulatory hub in lipid metabolism ( 85 ). To characterize 
miR-27b isoform diversity, we requantifi ed miRNA isomiRs 
in the same smRNA sequencing libraries generated in the 
aforementioned study. We found that   20% and   16% of 
the hepatic miR-27b reads from C57BL/6J mice were 3 ′ -
adenylated and 3 ′ -uridylated, respectively ( Fig. 3A , B ).  In 
comparison, miR-122, another key hepatic lipid miRNA, 
was found to be preferentially adenylated at its 3 ′ -end 
(  18% adenylation versus   3% uridylation) ( Fig. 3B ). 
miR-27b, miR-24-1, and miR-23b are poly-cistronic miRNAs, 
processed from the same primary transcript. In our data-
set, all three miRNAs were upregulated in dyslipidemic 
conditions ( 6 ); however, their NTA patterns were very dif-
ferent ( Fig. 3B, C ). The overall 3 ′ NTA frequency for miR-
27b was decreased in the livers of mice on high-fat diets, as 
both 3 ′ -adenylation and 3 ′ -uridylation were reduced by 
  1.6 and   1.8-fold, respectively ( Fig. 3C ,  Table 1 ) ( 85 ). 
 Contrastingly, miR-23b was found to be more highly 
3 ′ -adenylated (1.54-fold) and 3 ′ -uridylated (1.48-fold) in re-
sponse to high-fat diet ( Fig. 3C ,  Table 1 ). As in the case of 
miR-23b, the 3 ′ -adenylation frequency for miR-24 was also 
increased by high-fat diet, but substantially more so (  105-
fold) ( Table 1 ). Recently, another study using a panel of nine 
human tissues and cells demonstrated that miR-24 is among 
the most frequently 3 ′ -modifi ed miRNA ( 125 ). In healthy 
WT mice, 81% of the top 100 expressed miRNAs in the 
liver have some percentage of isomiRs with poly-adenyla-
tion (81/100 miRNAs had isomiRs with poly-adenylation), 
as opposed to 67% with poly-uridylation. Strikingly, the 
number of miRNAs (in top 100) with poly-adenylation and 
poly-uridylation in high-fat diet increased to 94% and 
85%, respectively. Although miR-27b and miR-24 isomiRs 
( 122 ) and the let-7 family ( 21 ). Other enzymes, such as 
zinc fi nger CCHC domain containing 11 (ZCCHC11) and 
terminal uridylyl transferase 1 (TUT1), catalyze either 3 ′ -
uridylation or 3 ′ -adenylation, depending on the miRNA 
( 19, 31 ). Interestingly, knockdown of PAPD5 and MTPAP 
also resulted in the reduced frequency of 3 ′ nontemplated 
“GA” for miR-1246 ( 19 ). While it is evident that nucleoti-
dyl transferases preferentially modify specifi c miRNAs, the 
sequence or structure features that determine how they 
select their targets remains unclear. 
 Currently, multiple strategies and platforms are avail-
able to detect and quantify miRNA isomiRs. A comprehen-
sive and exhaustive review on miRNA profi ling, methods, 
and approaches is found in Ref.  123 . The most widely used 
technique for the quantifi cation of canonical miRNAs is 
real-time PCR using individual assays or low-density arrays. 
However, this method is not well-suited for isomiR quanti-
fi cation, as reverse transcription primers and probes are 
not designed to detect 3 ′ -end variability. A signifi cant ad-
vantage of an alternate approach, high-throughput smRNA 
sequencing, is the ability to precisely resolve the 5 ′ - and 
3 ′ -ends of miRNA sequences ( 124 ). Massive parallel se-
quencing, often referred to as high-throughput sequenc-
ing, takes advantage of amplifi ed clusters of small length 
cDNA prepared from small RNAs or DNA fragments, 
which are then simultaneously sequenced by imaging. 
smRNA sequencing can be labor intensive and time-ineffi -
cient, and it also may not provide a means of linear quan-
tifi cation ( 125 ). Despite these limitations, the smRNA 
sequencing method is currently the most sensitive and, as 
such, has been the method of choice for isomiR analyses. 
A new, promising approach for isomiR analysis is digital 
 Fig.  2. Schematic of microRNA isomiRs. Nucleotidyl transferases 
add nontemplated nucleotides to the 3 ′ terminal end of miRNAs 
and alter miRNA loading onto Argonaute complexes and general 
miRNA stability. Poly-adenylation inhibits poly-uridylation and vice 
versa. Exonucleases trim 5 ′ terminal bases from mature miRNAs 
and generate novel miRNAs or “isomiRs” of canonical mature miR-
NAs. GLD-2, PAP-associated domain containing 4; MTPAP, mito-
chondrial poly(A) polymerase; PAPD5, PAP-associated domain 
containing 5; TUT1, terminal uridylyl transferase 1, U6 snRNA-
specifi c ZCCHC11, zinc fi nger, CCHC domain containing 11; 
ZCCHC6, zinc fi nger, CCHC domain containing 6. 
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NTAs have been demonstrated to alter AGO2-RISC load-
ing; therefore, some 3 ′ NTAs may also indirectly alter 
miRNA function. Here we describe for the fi rst time isomiR 
changes associated with high-fat diets or dyslipidemia; 
are frequent, diverse, and sensitive to metabolic condi-
tions, literature currently purports that 3 ′ -end NTAs do 
not mediate changes in direct miRNA targeting but, rather, 
alter miRNA stability and/or expression. Nevertheless, 3 ′ 
 Fig.  3. Hepatic miRNA isomiRs are differentially 
altered in diet-induced hyperlipidemia. (A) mmu-
miR-27b canonical, 3 ′ -adenylation and 3 ′ -uridylation 
reads (frequency) in normal chow and high-fat diet 
fed mouse livers, as determined by small RNA high-
throughput sequencing. (B) Frequency of mmu-
miR-122 (miR-122), mmu-miR-23b (miR-23b), and 
mmu-miR-27b-3p (miR-27b) 3 ′ terminal modifi ca-
tions in normal mouse liver. (C) Differential 3 ′ mod-
ifi cations to mature miR-23b and miR-27b in high-fat 
diet mouse livers compared with normal chow diet 
at three weeks (21% fat, Western diet). Presented as 
Log 2 (fold-change). (D) Frequency of miRNA non-
templated additions are not linked to miRNA ex-
pression levels. Frequency of mature miRNA 3 ′ 
terminal adenylation and uridylation in top 100 ex-
pressed miRNAs in mouse liver, as determined by 
small RNA high-throughput sequencing. Filled cir-
cles, 3 ′ adenylation; Open circles, 3 ′ uridylation. 
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deletion of miR-122 in mice (Mir122ko) was found to 
cause severe steatosis as a result of the signifi cant accumu-
lation of TG, but not cholesterol, in the liver ( 138 ). Spe-
cifi cally, de novo TG synthesis was found to be signifi cantly 
elevated while TG secretion was signifi cantly decreased in 
Mir122ko mice ( 138 ). Loss of liver miR-122 also resulted 
in decreased plasma total cholesterol, HDL-cholesterol, 
and LDL-cholesterol, but only a slight drop in plasma TG 
was reported ( 138 ). Most interestingly, 3 ′ -end adenylation 
by GLD-2 was found to stabilize miR-122, as GLD-2-null mice 
were reported to have increased levels of 3 ′ -uridylated 
miR-122 (degradation signal), decreased levels of mature 
miR-122, and increased levels of miR-122 target genes 
( 122 ). Although GLD-2 is quite possibly involved in the 
3 ′ -adenylation of other miRNAs, none other than miR-122 
was reported to have signifi cantly reduced 3 ′ -adenylation 
however, the mechanism responsible for miRNA variabil-
ity in the context of dyslipidemia is currently unknown. 
To our knowledge, none of the known NTA enzymes 
has been reported to be altered with high-fat diets or 
hyperlipidemia. 
 Canonical miR-122 and its isomiRs account for over 
80% of miRNAs present in the liver. As such, miR-122 is 
the most studied hepatic miRNA and is directly involved 
in hepatitis C infection ( 127, 128 ), cellular proliferation 
( 129, 130 ), differentiation ( 102 ), and tumor suppression 
( 131 ). miR-122 is also a critical regulator of hepatic lipid 
metabolism and systemic lipid homeostasis ( 40, 132–134 ). 
miR-122 is thought to be transcribed only in hepatocytes; 
however, miR-122 is present in extracellular fl uids ( 135, 
136 ), including plasma, and may be transferred to other 
cells by extracellular RNA carriers ( 137 ). Liver-specifi c 
 TABLE 1. Differential expression of hepatic miRNA isomiRs and NTA in high-fat diet mice 
miRNA isomiR isomiR Fold Change (HFD/Chow) NTA Fold Change A NTA Fold Change U
mmu-mir-194-2-5p 7.44 1.16 0.90
mmu-mir-24-1-3p 5.90 105.07 1.90
mmu-mir-24-2-3p 5.90 105.07 1.90
mmu-mir-194-1-5p 5.55 17.36 1.18
mmu-mir-26a-2-5p 5.42 6.41 119.64
mmu-mir-148a-3p 5.08 0.14 33.84
mmu-mir-16-1-5p 4.92 1.24 0.79
mmu-mir-26a-1-5p 4.44 7.82 146.06
mmu-mir-22-3p 3.37 0.73 0.44
mmu-mir-29c-3p 3.27 0.43 0.08
mmu-mir-21-5p 3.22 2.28 6.13
mmu-mir-29a-3p 3.14 3.34 0.19
mmu-let-7f-1-5p 3.09 1.97 200.55
mmu-mir-25-3p 3.03 0.75 0.25
mmu-mir-23a-3p 2.87 0.00 0.45
mmu-mir-27b-3p 2.85 0.63 0.57
mmu-mir-92a-1-3p 2.63 0.32 3788.75
mmu-mir-23b-3p 2.46 1.54 1.48
mmu-mir-126-3p 2.42 0.99 1.02
mmu-mir-142-3p_-_1 2.25 10.71 0.25
mmu-mir-140-3p 2.08 112.57 61845.86
mmu-mir-21-5p_+_2 2.05 0.34 9.58
mmu-mir-192-5p 1.81 1.05 0.54
mmu-mir-126-3p 1.69 1.14 1.13
mmu-mir-125b-2-5p 1.67 0.76 25979.11
mmu-mir-125b-1-5p 1.63 0.78 25979.11
mmu-mir-139-5p 1.47 0.71 0.00
mmu-mir-378-3p 1.30 0.00 0.65
mmu-let-7a-2-5p 1.04 0.83 77.53
mmu-let-7d-5p 1.02 1.10 0.00
mmu-mir-126-5p 0.98 0.87 0.50
mmu-mir-122-5p 0.95 1.29 0.64
mmu-mir-122-5p_-_1 0.88 0.93 0.00
mmu-let-7c-1-5p 0.86 1.18 0.42
mmu-mir-122-5p_+_1 0.73 1.05 0.14
mmu-mir-122-5p_-_1 0.72 1.36 0.59
mmu-mir-101b-3p 0.63 237.01 1.20
mmu-mir-29b-2-3p 0.60 1.05 17499.10
mmu-mir-29b-1-3p 0.59 1.08 19026.28
mmu-mir-122-5p_+_2 0.56 4.43 1.39
mmu-mir-122-5p_+_3 0.48 1.56 9.04
mmu-mir-130a-3p 0.48 1.39 0.55
mmu-let-7b-5p 0.46 1.05 0.28
mmu-mir-193-3p 0.38 1.92 1.46
mmu-mir-126-5p_+_2 0.34 0.86 1.42
mmu-mir-126-5p_+_1 0.32 0.87 2.47
mmu-mir-122-5p_+_4 0.29 1.43 1.12
mmu-mir-221-3p 0.26 1.38 0.37
+1 represents loss of 1 nucleotide on 5 ′ -end of mature canonical miRNA, and   1 represents additional 
nucleotide on 5 ′ end of canonical mature miRNA. HFD, high-fat diet.
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 • Frequency of miRNA nontemplated nucleotide addi-
tions is not directly correlated with miRNA expression 
levels. 
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in GLD-2-null mice ( 122 ). Notably, 3 ′ -adenylation may 
have different effects on different miRNAs, as 3 ′ -adenylation 
of miR-26a failed to alter stability but, rather, signifi cantly 
reduced targeting capacity ( 139 ). This apparent discrep-
ancy could be due differential nucleotide transfer enzymes, 
as miR-122 is poly-adenylated by GLD-2 and miR-26a was 
found to be poly-adenylated by ZCCHC11 ( 122, 139 ). Al-
though miR-122 is one of the most abundant miRNAs in 
the liver and one of the most highly modifi ed miRNAs, we 
found that overall the frequency of 3 ′ NTA is not corre-
lated with miRNA expression ( Fig. 3D ). 
 SUMMARY 
 The study of miRNAs has provided insights into novel 
molecular mechanisms that underlie complex disease eti-
ology. Accordingly, miRNAs have emerged as compelling 
drug targets for the treatment of numerous disorders, in-
cluding cardiovascular disease and dyslipidemia. Recent 
technological advances, such as next-generation sequenc-
ing, small biologics, and integrative computational tools, 
have facilitated rapid progress in the profi ling and func-
tional characterization of miRNAs. For example, there 
are now several cost-effi cient platforms and protocols for 
smRNA-seq, including those from Illumina, Life Technol-
ogies, and NanoString, that provide a high-resolution, 
digital representation of intracellular miRNA expression. 
Very recent computational analyses of smRNA-seq data 
have led to the discovery that many miRNAs are present in 
multiple isoforms, called isomiRs, indicating that the com-
plete repertoire of functional miRNAs is likely more com-
plex than previously appreciated. This review highlights 
the extensive diversity of miRNAs and the potential for 
complex posttranscriptional regulation of miRNAs as well 
as other noncoding smRNAs. In summary, miRNAs and 
other smRNAs control many facets of lipid metabolism, 
and this is not limited to the canonical forms but also likely 
includes related functional variants such as isomiRs.  
 PERSPECTIVES 
 • A diverse group of miRNAs and miRNA-like smRNAs 
control lipid metabolism. 
 • miR-27b is a posttranscriptional regulatory hub for 
lipid metabolism and regulates 27 genes related to lipid 
homeostasis. 
 • Many miRNAs previously reported to target lipid-
regulating genes are present in multiple isoforms, due to vari-
ous types of 5 ′ and 3 ′ posttranscriptional modifi cations. 
 • Multiple sequencing and nonsequencing-based meth-
ods facilitate the quantifi cation and analysis of miRNA 
isomiRs. 
 • 5 ′ variability likely alters miRNA targeting activity and 
biological function. 
 • 3 ′ nontemplated nucleotide additions are miRNA spe-
cifi c and alter miRNA stability and/or loading onto the 
RISC. 
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